Daniel Matthews, MD
Sports Medicine · Daphne, ALNPI 1225036569
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (52.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Avanos Medical accounts for 96.1% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2020 at $75,476 and has fallen 96.2% since, to $2,839 in 2025. Among sports medicine clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $827.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanos Medical$182K
- Smith+Nephew$4K
- Johnson & Johnson$740
- Medical Device Business Services, Inc.$465
- Bioventus LLC$445
- Amgen$320
- plus $1K from 23 others
Across 22 payments — averaging $10,511 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avanos Medical$176K
- Medical Device Business Services, Inc.$55K
What the payments were for
- Royalty or licence$98,95052%
- Consulting fees$76,80141%
- Speaking & faculty fees$5,3833%
- Travel & lodging$3,1352%
- Food & beverage$5,2553%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanos Medical | 59 | $182,085 |
| Smith+Nephew | 41 | $4,241 |
| Johnson & Johnson(2 entities) | 24 | $740 |
| Medical Device Business Services, Inc. | 1 | $465 |
| Bioventus LLC | 19 | $445 |
| Amgen | 29 | $320 |
| Pacira Therapeutics, Inc. | 12 | $209 |
| Kowa Pharmaceuticals America, Inc. | 15 | $173 |
| Pacira Pharmaceuticals Incorporated | 1 | $122 |
| Comsort, Inc | 1 | $100 |
| Orthalign Inc | 1 | $75 |
| Stryker | 2 | $56 |
| Heraeus Medical, LLC. | 4 | $53 |
| Kerecis Limited | 2 | $45 |
| DJO, LLC | 1 | $42 |
| Endo Pharmaceuticals Inc. | 2 | $39 |
| Vericel Corporation | 2 | $38 |
| Zyla Life Sciences, Inc. | 2 | $38 |
| Prime Surgical, LLC | 1 | $32 |
| Mimedx Group, Inc. | 1 | $27 |
| BD | 1 | $24 |
| Baudax Bio Inc. | 1 | $24 |
| Vertex | 1 | $24 |
| Medline Industries LP | 1 | $22 |
| Endo USA, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Chiesi USA, Inc. | 1 | $16 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ON-Q$104,333
- ON-Q* PUMP AND ACCESSORIES$46,201
- C-SERIES$25,725
- GENERATOR$5,150
- Journey II$1,794
- REAL INTELLIGENCE$1,693
- JOURNEY$1,543
- RI.HIP NAVIGATION$1,543
- POLARSTEM$1,151
- Journey II BCS$859
- POLARCUP$534
- KNEE3 Software$534
- Legion Revision$534
- Journey II XR$325
- NAVIO$325
- Acufex$130
- T-BLOC$123
- EXPAREL$122
- CORI$101
- ARIA$101
How this compares
$189,524 in reported general payments places this provider in the 95th percentile of 108 sports medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 240 | $2,551 |
| Oxycodone Hcl | 331 | $1,325 |
| Celecoxib | 69 | $1,029 |
| Ondansetron Hcl | 174 | $883 |
| Gabapentin | 189 | $610 |
| Omeprazole | 95 | $523 |
| Ciprofloxacin Hcl | 139 | $417 |
| Cephalexin | 32 | $341 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $299 |
| Scopolamine | 12 | $199 |
| Meloxicam | 75 | $168 |
| Tramadol Hcl | 56 | $155 |
| Mupirocin | 17 | $140 |
| Methylprednisolone | 14 | $137 |
| Tamsulosin Hcl | 54 | $117 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Daphne
- James SpainDaphne$22K
- Edward CainBirmingham$12.7M
- Mark RogersBirmingham$94K
- Amit MomayaBirmingham$77K
- Matthew SmithGuntersville$73K
- Christoper GarrettBirmingham$58K
- Jonathan IsbellHoover$55K
- James McMurtrieHuntsville$54K
- Reaves CrabtreeBirmingham$47K
- David AdkisonBirmingham$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.